Best Targeted therapy Clinics in Israel: 2 Top-Rated Centers

Prof. Dr. David Sarid, an Oxford-trained uro-oncology specialist with 30+ publications, leads the targeted therapy program at Sourasky Medical Center. The consultation with therapy planning may cost around $950, typically including genomic testing and multidisciplinary team review. The center offers Lutetium-177 PSMA therapy – one of few worldwide combining diagnostic PET/CT with targeted radionuclide treatment. JCI-accredited with a 90% oncology success rate, the hospital provides access to experimental therapies via clinical trials.

Assuta Medical Center offers targeted therapy with a focus on gastrointestinal and liver cancers, led by Dr. Riad Hadad, a specialist trained at the University of Toronto’s medical center and head of the liver, pancreas, and gallbladder department. Treatment may cost between $14,000 and $71,400. Dr. Hadad has authored 60 scientific publications and holds memberships in the European Society of Surgical Oncology and the European Hepato-Pancreato-Biliary Association.